-
2
-
-
30444437059
-
Suboptimal medication adherence in Parkinson's disease
-
Grosset K.A., Bone I., Grosset D.G. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005, 20:1502-1507.
-
(2005)
Mov Disord
, vol.20
, pp. 1502-1507
-
-
Grosset, K.A.1
Bone, I.2
Grosset, D.G.3
-
3
-
-
33947313314
-
Treatment of Parkinson's disease: a survey of patients and neurologists
-
Fargel M., Grobe B., Oesterle E., Hastedt C., Rupp M. Treatment of Parkinson's disease: a survey of patients and neurologists. Clin Drug Invest 2007, 27:207-218.
-
(2007)
Clin Drug Invest
, vol.27
, pp. 207-218
-
-
Fargel, M.1
Grobe, B.2
Oesterle, E.3
Hastedt, C.4
Rupp, M.5
-
4
-
-
0034871011
-
A systematic review of the associations between dose regimens and medication compliance
-
Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.
-
(2001)
Clin Ther
, vol.23
, pp. 1296-1310
-
-
Claxton, A.J.1
Cramer, J.2
Pierce, C.3
-
5
-
-
66249091092
-
Adherence to antiparkinson medication in a multicenter European study
-
Grosset D., Antonini A., Canesi M., Pezzoli G., Lees A., Shaw K., et al. Adherence to antiparkinson medication in a multicenter European study. Mov Disord 2009, 24:826-832.
-
(2009)
Mov Disord
, vol.24
, pp. 826-832
-
-
Grosset, D.1
Antonini, A.2
Canesi, M.3
Pezzoli, G.4
Lees, A.5
Shaw, K.6
-
6
-
-
0142186036
-
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain
-
Kornick C.A., Santiago-Palma J., Moryl N., Payne R., Obbens E.A. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 2003, 26:951-973.
-
(2003)
Drug Saf
, vol.26
, pp. 951-973
-
-
Kornick, C.A.1
Santiago-Palma, J.2
Moryl, N.3
Payne, R.4
Obbens, E.A.5
-
7
-
-
23044468859
-
Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception
-
Urdl W., Apter D., Alperstein A., Koll P., Schönian S., Bringer J., et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005, 121:202-210.
-
(2005)
Eur J Obstet Gynecol Reprod Biol
, vol.121
, pp. 202-210
-
-
Urdl, W.1
Apter, D.2
Alperstein, A.3
Koll, P.4
Schönian, S.5
Bringer, J.6
-
8
-
-
33846438955
-
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
-
Watts R.L., Jankovic J., Waters C., Rajput A., Boroojerdi B., Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology 2007, 68:272-276.
-
(2007)
Neurology
, vol.68
, pp. 272-276
-
-
Watts, R.L.1
Jankovic, J.2
Waters, C.3
Rajput, A.4
Boroojerdi, B.5
Rao, J.6
-
9
-
-
34248372064
-
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
-
Poewe W.H., Rascol O., Quinn N., Tolosa E., Oertel W.H., Martignoni E., et al. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 2007, 6:513-520.
-
(2007)
Lancet Neurol
, vol.6
, pp. 513-520
-
-
Poewe, W.H.1
Rascol, O.2
Quinn, N.3
Tolosa, E.4
Oertel, W.H.5
Martignoni, E.6
-
10
-
-
40849113591
-
Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
-
Oertel W.H., Beneš H., García-Borreguero D., Geisler P., Högl B., Saletu B., et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2008, 9:228-239.
-
(2008)
Sleep Med
, vol.9
, pp. 228-239
-
-
Oertel, W.H.1
Beneš, H.2
García-Borreguero, D.3
Geisler, P.4
Högl, B.5
Saletu, B.6
-
11
-
-
49849083845
-
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
-
Trenkwalder C., Beneš H., Poewe W., Oertel W.H., García-Borreguero D., de Weerd A.W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604.
-
(2008)
Lancet Neurol
, vol.7
, pp. 595-604
-
-
Trenkwalder, C.1
Beneš, H.2
Poewe, W.3
Oertel, W.H.4
García-Borreguero, D.5
de Weerd, A.W.6
-
12
-
-
34547404736
-
Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease
-
(abstract P1245)
-
Braun M., Cawello W., Poole K., Horstmann R. Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease. Eur J Neurol 2005, 12(SSSS):37-300. (abstract P1245).
-
(2005)
Eur J Neurol
, vol.12
, Issue.SUPPL. 2
, pp. 37-300
-
-
Braun, M.1
Cawello, W.2
Poole, K.3
Horstmann, R.4
-
13
-
-
34247208187
-
Advanced Parkinson disease treated with rotigotine transdermal system. PREFER Study
-
LeWitt P.A., Lyons K.E., Pahwa R. Advanced Parkinson disease treated with rotigotine transdermal system. PREFER Study. Neurology 2007, 68:1262-1267.
-
(2007)
Neurology
, vol.68
, pp. 1262-1267
-
-
LeWitt, P.A.1
Lyons, K.E.2
Pahwa, R.3
-
14
-
-
50649105757
-
Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease
-
Setter S.M. Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease. Neurol Clin 2008, 26:S45-S63.
-
(2008)
Neurol Clin
, vol.26
-
-
Setter, S.M.1
-
15
-
-
67649377884
-
-
Available at:, [accessed 03.05.09]
-
® transdermal patch. Package label Available at:, [accessed 03.05.09]. http://www.emea.europa.eu/humandocs/PDFs/EPAR/neupro/H-626-PI-en.pdf.
-
® transdermal patch. Package label
-
-
-
16
-
-
0022632510
-
Concurrent and predictive validity of a self-reported measure of medication adherence
-
Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
-
(1986)
Med Care
, vol.24
, pp. 67-74
-
-
Morisky, D.E.1
Green, L.W.2
Levine, D.M.3
-
17
-
-
0041384468
-
The impact of reducing dose frequency on health outcomes
-
Richter A., Anton S.F., Koch P., Dennett S.L. The impact of reducing dose frequency on health outcomes. Clin Ther 2003, 25:2307-2335.
-
(2003)
Clin Ther
, vol.25
, pp. 2307-2335
-
-
Richter, A.1
Anton, S.F.2
Koch, P.3
Dennett, S.L.4
-
18
-
-
0024343414
-
How often is medication taken as prescribed? A novel assessment technique
-
Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989, 261:3273-3277.
-
(1989)
JAMA
, vol.261
, pp. 3273-3277
-
-
Cramer, J.A.1
Mattson, R.H.2
Prevey, M.L.3
Scheyer, R.D.4
Ouellette, V.L.5
-
19
-
-
77956169807
-
Improved self-reported compliance with transdermal (patch) versus oral medication in Parkinson's disease patients
-
(abstract P1175)
-
Grosset D., Grosset K., Emmermann A., Hastedt C., Tischer B. Improved self-reported compliance with transdermal (patch) versus oral medication in Parkinson's disease patients. Eur J Neurol 2006, 13(Suppl. 2):88-89. (abstract P1175).
-
(2006)
Eur J Neurol
, vol.13
, Issue.SUPPL. 2
, pp. 88-89
-
-
Grosset, D.1
Grosset, K.2
Emmermann, A.3
Hastedt, C.4
Tischer, B.5
-
20
-
-
61949226675
-
Treatments for Parkinson disease past achievements and current clinical needs
-
Poewe W. Treatments for Parkinson disease past achievements and current clinical needs. Neurology 2009, 72:S65-S73.
-
(2009)
Neurology
, vol.72
-
-
Poewe, W.1
-
21
-
-
0346754905
-
A controlled trial of rotigotine monotherapy in early Parkinson's disease
-
Parkinson Study Group
-
Parkinson Study Group A controlled trial of rotigotine monotherapy in early Parkinson's disease. Arch Neurol 2003, 60:1721-1728.
-
(2003)
Arch Neurol
, vol.60
, pp. 1721-1728
-
-
-
22
-
-
38549159427
-
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole
-
Giladi N., Boroojerdi B., Korczyn A.D., Burn D.J., Clarke C.E., Schapira A.H.V. Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord 2007, 22:2398-2404.
-
(2007)
Mov Disord
, vol.22
, pp. 2398-2404
-
-
Giladi, N.1
Boroojerdi, B.2
Korczyn, A.D.3
Burn, D.J.4
Clarke, C.E.5
Schapira, A.H.V.6
|